IGF1 and breast carcinoma: Research has shown that the binding of insulin and IGF‐1 to the insulin receptor can activate the PI3K/AKT/mTORC signaling pathway, stimulating cell proliferation and the transcription of metabolic genes, which promotes the growth of cancer cells and prevents apoptosis in breast cancer cells [15].